Literature DB >> 19706847

Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.

Linda M Dong1, Cornelia M Ulrich, Li Hsu, David J Duggan, Debbie S Benitez, Emily White, Martha L Slattery, Fred M Farin, Karen W Makar, Christopher S Carlson, Bette J Caan, John D Potter, Ulrike Peters.   

Abstract

Genetic association studies investigating the role of vitamin D in colon cancer have primarily focused on the vitamin D receptor (VDR), with limited data available for other genes in the vitamin D pathway, including vitamin D activating enzyme 1-alpha hydroxylase (CYP27B1) and vitamin D deactivating enzyme 24-alpha hydroxylase (CYP24A1). We evaluated whether 12 tagging single nucleotide polymorphisms (SNP) in CYP24A1, identified by resequencing the gene in 32 Caucasian samples, and 1 SNP in CYP27B1 were associated with colon cancer risk. In addition, we evaluated whether these two genes modify associations between colon cancer on the one hand and total vitamin D intake and UV-weighted sun exposure on the other, as well as other variants in VDR. Unconditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (95% CI) for the association between polymorphisms and haplotypes in CYP27B1 and CYP24A1 in a multicenter population-based case-control study of 1,600 cases and 1,949 controls. The CYP24A1 polymorphism IVS4-66T > G showed a statistically significant association with risk of colon cancer overall, particularly for proximal colon cancer. When stratified by anatomic site, we also found statistically significant associations for three CYP24A1 polymorphisms with risk of distal colon cancer (IVS4 + 1653C > T: OR for CT/TT versus CC, 0.81; 95% CI, 0.68-0.96; IVS9 + 198T > C: OR for CC versus TT, 1.33; 95% CI, 1.03-1.73; and within whites only: +4125bp 3' of STPC > G: OR for GG versus CC, 1.44; 95% CI, 1-2.05). In addition, a possible interaction between CYP27B1 and UV-weighted sun exposure with proximal colon cancer was observed. As this is the first study to evaluate these genes in relation to colon cancer, additional studies are needed to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706847      PMCID: PMC2761078          DOI: 10.1158/1055-9965.EPI-09-0228

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  50 in total

1.  The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus.

Authors:  S A Tishkoff; A J Pakstis; G Ruano; K K Kidd
Journal:  Am J Hum Genet       Date:  2000-06-19       Impact factor: 11.025

Review 2.  Nonclassical effects of 1alpha,25-dihydroxyvitamin D(3) and its analogs.

Authors:  A Verstuyf; L Verlinden; S Segaert; E Van Etten; C Mathieu; R Bouillon
Journal:  Miner Electrolyte Metab       Date:  1999 Jul-Dec

3.  Prediction of deleterious human alleles.

Authors:  S Sunyaev; V Ramensky; I Koch; W Lathe; A S Kondrashov; P Bork
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

4.  Predictive identification of exonic splicing enhancers in human genes.

Authors:  William G Fairbrother; Ru-Fang Yeh; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

5.  Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas.

Authors:  U Peters; K A McGlynn; N Chatterjee; E Gunter; M Garcia-Closas; N Rothman; R Sinha
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-12       Impact factor: 4.254

6.  Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States).

Authors:  E Kampman; M L Slattery; B Caan; J D Potter
Journal:  Cancer Causes Control       Date:  2000-05       Impact factor: 2.506

7.  Objective system for interviewer performance evaluation for use in epidemiologic studies.

Authors:  S Edwards; M L Slattery; M Mori; T D Berry; B J Caan; P Palmer; J D Potter
Journal:  Am J Epidemiol       Date:  1994-12-01       Impact factor: 4.897

8.  Variants of the VDR gene and risk of colon cancer (United States).

Authors:  M L Slatter; K Yakumo; M Hoffman; S Neuhausen
Journal:  Cancer Causes Control       Date:  2001-05       Impact factor: 2.506

9.  Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.

Authors:  E A Platz; S E Hankinson; B W Hollis; G A Colditz; D J Hunter; F E Speizer; E Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-10       Impact factor: 4.254

10.  25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue.

Authors:  V Tangpricha; J N Flanagan; L W Whitlatch; C C Tseng; T C Chen; P R Holt; M S Lipkin; M F Holick
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

View more
  33 in total

1.  Gene-diet interactions and their impact on colorectal cancer risk.

Authors:  Elizabeth D Kantor; Edward L Giovannucci
Journal:  Curr Nutr Rep       Date:  2015-03

Review 2.  Hereditary and familial colon cancer.

Authors:  Kory W Jasperson; Thérèse M Tuohy; Deborah W Neklason; Randall W Burt
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

3.  Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic.

Authors:  David J Hughes; Ivona Hlavatá; Pavel Soucek; Barbara Pardini; Alessio Naccarati; Ludmila Vodickova; Mazda Jenab; Pavel Vodicka
Journal:  J Gastrointest Cancer       Date:  2011-09

Review 4.  Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches.

Authors:  Davide Serrano; Matteo Lazzeroni; Bernardo Bonanni
Journal:  Mol Oncol       Date:  2014-12-20       Impact factor: 6.603

Review 5.  Nutrigenomics, vitamin D and cancer prevention.

Authors:  Cindy D Davis; John A Milner
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-03-23

6.  CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells.

Authors:  Elizabeth T Jacobs; Chad Van Pelt; Ryan E Forster; Wasiq Zaidi; Elizabeth A Hibler; Michael A Galligan; Mark R Haussler; Peter W Jurutka
Journal:  Cancer Res       Date:  2013-02-19       Impact factor: 12.701

Review 7.  Cytochromes p450 and skin cancer: role of local endocrine pathways.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Igor Semak; Blazej Zbytek; Alexander Pisarchik; Wei Li; Jordan Zjawiony; Robert C Tuckey
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

8.  Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer.

Authors:  Linda T Hiraki; Conghui Qu; Carolyn M Hutter; John A Baron; Sonja I Berndt; Stéphane Bézieau; Hermann Brenner; Bette J Caan; Graham Casey; Jenny Chang-Claude; Stephen J Chanock; David V Conti; David Duggan; Charles S Fuchs; Steven Gallinger; Edward L Giovannucci; Tabitha A Harrison; Richard B Hayes; Aditi Hazra; Brian Henderson; Michael Hoffmeister; John L Hopper; Thomas J Hudson; Mark A Jenkins; Sébastien Küry; Loic Le Marchand; Mathieu Lemire; Jing Ma; Joann E Manson; Hongmei Nan; Polly A Newcomb; Kimmie Ng; John D Potter; Robert E Schoen; Fredrick R Schumacher; Daniela Seminara; Martha L Slattery; Jean Wactawski-Wende; Emily White; Kana Wu; Brent W Zanke; Peter Kraft; Ulrike Peters; Andrew T Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

9.  Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer.

Authors:  Barbara J Fuhrman; D Michal Freedman; Parveen Bhatti; Michele M Doody; Yi-Ping Fu; Shih-Chen Chang; Martha S Linet; Alice J Sigurdson
Journal:  Anticancer Res       Date:  2013-02       Impact factor: 2.480

10.  CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence.

Authors:  Elizabeth A Hibler; Yann C Klimentidis; Peter W Jurutka; Lindsay N Kohler; Peter Lance; Denise J Roe; Patricia A Thompson; Elizabeth T Jacobs
Journal:  Nutr Cancer       Date:  2015-08-04       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.